PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.7460
-0.0060 (-0.80%)
At close: Jul 15, 2026, 4:00 PM EDT
0.7311
-0.0149 (-2.00%)
After-hours: Jul 15, 2026, 6:30 PM EDT
PDS Biotechnology Employees
PDS Biotechnology had 21 employees as of December 31, 2025. The number of employees decreased by 3 or -12.50% compared to the previous year.
Employees
21
Change (1Y)
-3
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$1,588,362
Market Cap
41.64M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 21 | -3 | -12.50% |
| Dec 31, 2024 | 24 | -1 | -4.00% |
| Dec 31, 2023 | 25 | -1 | -3.85% |
| Dec 31, 2022 | 26 | 4 | 18.18% |
| Dec 31, 2021 | 22 | 7 | 46.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Veru Inc. | 20 |
| RenovoRx | 17 |
| Lantern Pharma | 16 |
| CervoMed | 15 |
| Apollomics | 14 |
| Nutriband | 13 |
| Actuate Therapeutics | 12 |
| Hyperion DeFi | 9 |
PDSB News
- 5 days ago - PDS Biotechnology registers to sell 13.32M shares of common stock for holders - TheFly
- 5 days ago - PDS Biotechnology Registration statement: Registration filing - Filings
- 19 days ago - PDS Biotechnology Proxy statement: Proxy filing - Filings
- 19 days ago - PDS Biotechnology Proxy statement: Proxy filing - Filings
- 4 weeks ago - PDS Biotechnology Proxy statement: Proxy filing - Filings
- 2 months ago - PDS Biotechnology Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - PDS Biotechnology Earnings release: Q1 2026 - Filings
- 2 months ago - PDS Biotechnology Quarterly report: Q1 2026 - Filings